News | 20 February 2013
The overall ratings of five Biotechnology stocks are down on Portfolio Grader this week. Each of these rates a ?D? (?sell?) or ?F? overall (?strong sell?). Targacept's (NASDAQ:TRGT) rating falls this week to an F (?strong sell?), down from last week's ...
Click on the link to read the full article at Investorplace.com
(This link will open in a new window)